Sempra

SRE is in a Stage 3 distribution regime with a confirmed Support Failure, driving a bearish medium-term bias. Price remains below the down-sloping 9/21 EMA cluster and shows no exhaustion, favoring continued downside. Under the Stable strategy, we prefer selling into rallies at the EMA resistance zone to align with ongoing supply pressure.

• ↑$65B 2026–2030 capex plan (+17%) targets US utility growth.
• ↑Q1 EPS $1.51 vs $1.44 YoY; 2026 EPS guidance $4.80–$5.30.
• ↓P/E 32.1x vs industry 18.9x indicates overvalued shares.